Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 13/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16294761 | 0.82 | APP (0.52) | APPCYP1A2POLBKDM4EALDH1A1 | |
| SCHEMBL15354678 | 0.81 | APP (0.43) | APPCYP1A2POLBSLC6A3 | |
| SCHEMBL12714382 | 0.79 | APP (0.63) | APPCYP1A2SNCA | |
| SCHEMBL10138091 | 0.79 | APP (0.43) | APPCYP1A2SLC6A3ALDH1A1HPGD | |
| SCHEMBL15354677 | 0.79 | APP (0.43) | APPCYP1A2SLC6A3TSHR | |
| SCHEMBL4922053 | 0.77 | APP (0.57) | APPCYP1A2FFAR1SLC6A3 | |
| SCHEMBL12714429 | 0.77 | APP (0.63) | APPCYP1A2SNCA | |
| Butyric Acid SCHEMBL381472 | 0.76 | APP (0.74) | APPCYP1A2SNCAPOLBKDM4E | |
| SCHEMBL3423545 | 0.76 | APP (0.44) | APPCYP1A2ALDH1A1HPGDTSHR | |
| Levulinic Acid SCHEMBL8512310 | 0.75 | APP (0.73) | APPCYP1A2SNCAPOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569516-B2 | Compounds and methods for fluorescent labeling | ELITECH HOLDING B.V. (NL) | 2013-10-29 | — | — | US | disclosed |
| US-8569516-B2 | Compounds and methods for fluorescent labeling | ELITECH HOLDING B.V. (NL) | 2013-10-29 | — | — | US | disclosed |
| US-7601851-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| EP-1991705-A4 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES INC (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-1991705-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | Epoch Biosciences, Inc. (US) | 2008-11-19 | — | — | EP | disclosed |
| EP-1466176-A4 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES INC (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007098336-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2007-08-30 | — | — | WO | disclosed |
| US-7112684-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2006-09-26 | — | — | US | disclosed |
| US-20060204990-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2006-09-14 | — | — | US | disclosed |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-15 | — | — | US | disclosed |
| US-6972339-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-06 | — | — | US | disclosed |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-08-11 | — | — | US | disclosed |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-08-04 | — | — | US | disclosed |
| EP-1466176-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | Epoch Biosciences, Inc. (US) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003023357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2003-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | APP 3054/4885CYP1A2 3646/4885SNCA 4329/4885 |
| US-20060204990-A1 | Compounds and methods for fluorescent labeling | GLB1, HLCS, PFAS | APP 3147/4885CYP1A2 3297/4885SNCA 3980/4885 |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | HLCS, GLB1, TUBB | APP 3054/4885CYP1A2 3646/4885SNCA 4329/4885 |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | APP 3054/4885CYP1A2 3646/4885SNCA 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.